RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
Journal of Clinical Investigation · 15.06.2023 · 133 (12)
DOI: 10.1172/jci165510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.06.2023. Verfasst von Jian-Gang Ren und 14 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine, Ministry of Education, Sc…. Hauptthemen laut MEDLINE: Lipoylation, Leukemia, Myeloid. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
RAS mutations are among the most prevalent oncogenic drivers in cancers. RAS proteins propagate signals only when associated with cellular membranes as a consequence of lipid modifications that impact their trafficking. Here, we discovered that RAB27B, a RAB family small GTPase, controlled NRAS palmitoylation and trafficking to the plasma membrane, a localization required for activation. Our proteomic studies revealed RAB27B upregulation in CBL- or JAK2-mutated myeloid malignancies, and its expression correlated with poor prognosis in acute myeloid leukemias (AMLs). RAB27B depletion inhibited the growth of CBL-deficient or NRAS-mutant cell lines. Strikingly, Rab27b deficiency in mice abrogated mutant but not WT NRAS-mediated progenitor cell growth, ERK signaling, and NRAS palmitoylation. Further, Rab27b deficiency significantly reduced myelomonocytic leukemia development in vivo. Mechanistically, RAB27B interacted with ZDHHC9, a palmitoyl acyltransferase that modifies NRAS. By regulating palmitoylation, RAB27B controlled c-RAF/MEK/ERK signaling and affected leukemia development. Importantly, RAB27B depletion in primary human AMLs inhibited oncogenic NRAS signaling and leukemic growth. We further revealed a significant correlation between RAB27B expression and sensitivity to MEK inhibitors in AMLs. Thus, our studies presented a link between RAB proteins and fundamental aspects of RAS posttranslational modification and trafficking, highlighting future therapeutic strategies for RAS-driven cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, Chin…
- Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Biochemistry, School of Medicine at the Southern University of Science and Technology, Shenzhen, Guangdong, China.
- Department of Medicine and Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, New York, USA.
- Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institutes of Health, U.S.A
Zitieren
APA
Ren, J. G., Xing, B., Lv, K., O'Keefe, R. A., Wu, M., Wang, R., Bauer, K. M., Ghazaryan, A., Burslem, G. M., Zhang, J., O'Connell, R. M., Pillai, V., Hexner, E. O., Philips, M. R., & Tong, W. (2023). RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. Journal of Clinical Investigation, 133(12). https://doi.org/10.1172/jci165510
Vancouver
Ren JG, Xing B, Lv K, O'Keefe RA, Wu M, Wang R, et al. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. Journal of Clinical Investigation. 2023;133(12). doi:10.1172/jci165510
BibTeX
@article{Ren2023,
author = {Ren, Jian-Gang and Xing, Bowen and Lv, Kaosheng and O'Keefe, Rachel A and Wu, Mengfang and Wang, Ruoxing and Bauer, Kaylyn M and Ghazaryan, Arevik and Burslem, George M and Zhang, Jing and O'Connell, Ryan M and Pillai, Vinodh and Hexner, Elizabeth O and Philips, Mark R and Tong, Wei},
title = {RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {12},
doi = {10.1172/jci165510}
}
EUVIMED